2001 REGULAR SESSION (71st)                                                                          A AB667 1000

Amendment No. 1000

 

Assembly Amendment to Assembly Bill No. 667                                                                (BDR 2‑1559)

Proposed by: Select Committee on Health and Legal Issues

Amendment Box:

Resolves Conflicts with: N/A

Amends:         Summary:              Title:              Preamble:               Joint Sponsorship:

 

ASSEMBLY ACTION              Initial and Date              |SENATE ACTION                        Initial and Date

       Adopted       Lost                                               |          Adopted       Lost                                           

Concurred In                     Not                                                        |Concurred In  Not                                 

       Receded        Not                                               |         Receded        Not                                           

 

     Amend section 1, page 1, by deleting lines 3 through 7 and inserting:

     “1.  Except as otherwise provided in subsection 2, a cause of action:

     (a) Against a manufacturer of:

          (1) Silicone manufactured for injection into the body; or

          (2) Breast implants containing silicone gel;

     (b) Based upon personal injury or death caused by the effects of silicone injected or implanted into the body; and

     (c) That was barred as of July 1, 2001, solely because the applicable period of limitation expired,

FLUSH

 
is hereby revived, and an action thereon may be commenced not later than July 1, 2002. A court”.

     Amend section 1, page 1, line 10, by deleting “2003.” and inserting “2002.”.

     Amend the title of the bill, second line, by deleting “gel injected” and inserting:

“injected or implanted”.

     Amend the summary of the bill to read as follows:

“SUMMARY—Revives for limited time certain causes of action based on effects of silicone injected or implanted into body. (BDR 2‑1559)”.